P/N: 9735023, DRIVER 9735023 SOLERA 5.5/6.0 MAS; P/N: 9735024, DRIVER 9735024 SOLERA 5.5/6.0 MAS ...
FDA Device Recall #Z-2823-2015 — Class II — September 14, 2015
Recall Summary
| Recall Number | Z-2823-2015 |
| Classification | Class II — Moderate risk |
| Date Initiated | September 14, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Medtronic Navigation, Inc. |
| Location | Louisville, CO |
| Product Type | Devices |
| Quantity | 2,346 |
Product Description
P/N: 9735023, DRIVER 9735023 SOLERA 5.5/6.0 MAS; P/N: 9735024, DRIVER 9735024 SOLERA 5.5/6.0 MAS CAN; P/N: 9735025, DRIVER 9735025 SOLERA 5.5/6.0 RMAS; P/N: 9735026, DRIVER 9735026 SOLERA 5.5/6.0 RMAS CAN; P/N: 9735027,DRIVER 9735027 SOLERA 5.5/6.0 FAS/SAS. The Medtronic Navigated Solera Screwdrivers are reusable devices that are designed for use in spine surgery to assist in the placement of screws during the surgery, using a Medtronic computer-assisted surgery system.
Reason for Recall
Specific use conditions can increase the possibility of a screwdriver tip deforming or breaking during surgery.
Distribution Pattern
Worldwide Distribution - US (nationwide) and Internationally to Canada; United Arab Emirates; Australia; Belgium; Switzerland; China; Germany; Denmark; Spain; Finland; France; Great Britain; Greece; India; Israel; Italy; Japan; Netherlands; New Zealand; Poland; Portugal; Sweden; Singapore; Thailand; Slovakia; Turkey; and South Africa.
Lot / Code Information
For this action, device lot numbers are not applicable. The action covers all lots of products distributed between September 2010 and July 2015
Other Recalls from Medtronic Navigation, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1022-2025 | Class II | Medtronic PIN, 100mm STERILE PERCUTANEOUS REF: ... | Dec 4, 2024 |
| Z-0050-2025 | Class II | StealthStation S8 App versions 1.3.0 and 1.3.2,... | Aug 22, 2024 |
| Z-1776-2024 | Class I | Stealth S8 Clinical Software Application, REF: ... | Mar 26, 2024 |
| Z-0698-2024 | Class II | Medtronic, REF 9733235, Pin, 100mm, STERILE, PE... | Nov 28, 2023 |
| Z-0699-2024 | Class II | Medtronic, REF 9733236, Pin, 150mm, STERILE, PE... | Nov 28, 2023 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.